Table 5.
Contribution of cellblock to the yield of EBUS-TBNA (benign or malignant cases)
| Studies | No. of patients (patient selection) | Mean age (years) | Yield with smear alone (%) | Yield with smear and CB combined (%) |
|---|---|---|---|---|
| Gauchotte G et al. (2012)[3] | 290 (consecutive) | 61.6 | 72.8 | 81.4 |
| Jose Sanz-Santos et al. (2012)[18] | 270 (lung cancer) | 63.3 | 72.9 | 80 |
| Wang H et al. (2012)[19] | 61 (consecutive) | 48.6 | 21.7 | 80.4 |
| Rotolo N (2017)[20] | 199 (consecutive) | 64 | 81 | 86 |
| Our Study [2017] | 217 (consecutive) | 48.4 | 80.6 | 84.8 |